Coming to "Grp(s)" with Senescence in the Alveolar Epithelium.

Coming to "Grp(s)" with Senescence in the Alveolar Epithelium.
复制标题

来到“Grp(s)”,肺泡上皮细胞衰老。

DOI:
10.1164/rccm.201910-2052ed
复制
发表时间:
2020
影响因子:
24.7
通讯作者:
Kropski,JonathanA
Kropski,JonathanA
中科院分区:
医学1区
文献类型:
--
作者:
Winters,NichelleI;Kropski,JonathanA

文献摘要

相似文献

7. Taylor-Mendar JL,Jain M,Barto TL,Haddad T,Atkinson J,Tian S,et al.; VX 14 -809-106研究者小组。鲁玛卡托/依伐卡托治疗囊性纤维化和F508 del-CFTR纯合子晚期肺病患者J Cyst Fibros 2018; 17:228-235. 8. Hubert D,Chiron R,Camara B,Grenet D,Prévotat A,Bassinet L,et al. Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe 508 del CFTR mutation and severe lung disease. J Cyst Fibros 2017; 16:388-391. 9. Jennings MT,Dezube R,Paranjape S,West NE,Hong G,Braun A,et al.一项对使用lumacaftor/ivacaftor治疗的囊性纤维化患者的结局和耐受性的观察性研究。Ann Am Thorac Soc 2017; 14:1662-1666.
7. Taylor-Cousar JL, Jain M, Barto TL, Haddad T, Atkinson J, Tian S, et al.; VX14-809-106 Investigator Group. Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR. J Cyst Fibros 2018; 17: 228-235. 8. Hubert D, Chiron R, Camara B, Grenet D, Prévotat A, Bassinet L, et al. Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease. J Cyst Fibros 2017; 16: 388-391. 9. Jennings MT, Dezube R, Paranjape S, West NE, Hong G, Braun A, et al. An observational study of outcomes and tolerances in patients with cystic fibrosis initiated on lumacaftor/ivacaftor. Ann Am Thorac Soc 2017; 14: 1662-1666.